Innovent Biologics announces positive Phase 2 results for Efdamrofusp Alfa in nAMD

In an important development for the treatment of neovascular age-related macular degeneration (nAMD), Innovent Biologics, Inc., a leading biopharmaceutical company, has announced successful results from ... Read More